Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
In 2016, Patheon successfully completed 111 technology transfers to help our clients safeguard supply, improve distribution and reduce program costs and risks. This has allowed firms to take advantage of specialist expertise, solid processes and standardized operating procedures and equipment.
Download our whitepaper to learn how the benefits of engaging in a well-planned transfer of production can outweigh the risks.
Authors:
Thomas Dax, Director External Manufacturing, API, Patheon
Mirko Gabriele, Global DPS Technology Transfer Sr. Manager, Patheon
Paul Jorjorian, Director Global Technology Transfer, Patheon